Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong · Delayed Price · Currency is HKD 2.230
-0.060 (-2.62%)
Oct 9, 2026, 4:08 PM HKT
Hua Medicine (Shanghai) Market Cap
Hua Medicine (Shanghai) has a market cap or net worth of 2.23 billion as of October 9, 2026. It is the 18,815th most valuable company in the world and the 834th biggest in Hong Kong. Its market cap has decreased by 53.43% in one year.
Market Cap
2.23B
Enterprise Value
1.40B
Revenue
755.49M
Global Rank
Country Rank
#834 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since September 14, 2018, Hua Medicine (Shanghai)'s market cap has decreased from 8.71B to 2.23B, a decrease of -74.43%. That is a compound annual growth rate of -15.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 2.23B | -26.82% |
| Dec 31, 2025 | 3.04B | 112.44% |
| Dec 31, 2024 | 1.43B | -25.71% |
| Dec 29, 2023 | 1.93B | -46.67% |
| Dec 30, 2022 | 3.62B | -0.33% |
| Dec 31, 2021 | 3.63B | -34.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xuanzhu Biopharmaceutical | 4.34B |
| Edding Genor Group Holdings | 3.36B |
| CF PharmTech | 2.46B |
| VISEN Pharmaceuticals | 2.03B |
| CPBIO Holding Company | 2.01B |
| Jacobson Pharma Corporation | 1.94B |
| Dawnrays Pharmaceutical (Holdings) | 1.45B |
| Golden Throat Holdings Group Company | 1.42B |